现在位置 >首页 > 进展交流
[Clin Infect Dis发表论文]:澳大利亚住院儿童革兰阴性菌感染的特征及临床预后已关闭评论
Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes  Sophie C H Wen,  Patrick N A Harris,  Brian Forde,  et al Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 734–743, https://doi.org/10.1093/cid/ciae341 Abstract Background Gram-negative bloodstream infections (GNBSIs) more commonly occur in children with comorbidities and ...
阅读全文
[JAMA发表论文]:私募股权公司与上市公司的安养院护理员报告的照护质量已关闭评论
Research Letter  November 18, 2024 Caregiver-Reported Quality in Hospices Owned by Private Equity Firms and Publicly Traded Companies Alexander E. Soltoff, Mark Aaron Unruh, David G. Stevenson, et al JAMA. Published online November 18, 2024. doi:10.1001/jama.2024.20546 The US hospice industry has shifted from not-for-profit to for-profit ownership models,1,2producing concerns about care quality. For-profit h...
阅读全文
[ICU Management & Practice]: 早期活动:仅仅是时尚吗?已关闭评论
Early Mobilisation: Just a Fad?  In ICU Tue, 1 Oct 2024 ICU Management & Practice, Volume 24 - Issue 4, 2024 A review of recent evidence on early mobilisation and rehabilitation and what remains to be defined. Introduction Critical illnesses encompass a broad spectrum of pathologies that require support for different organs. This often leads to prolonged bed rest and secondary immobilisation, which ultimately fosters the development ...
阅读全文
[Clin Infect Dis发表论文]:重度烧伤患者真菌感染的危险因素及预后已关闭评论
Risk Factors and Outcome Associated With Fungal Infections in Patients With Severe Burn Injury: 10-year Retrospective IFI-BURN Study  Emmanuel Dudoignon,  Sylvie Chevret,  Sorel Tsague,  et al Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 682–689, https://doi.org/10.1093/cid/ciae337 Abstract Background In burn patients, skin barrier disruption and immune dysfunctions increase susceptibilit...
阅读全文
[BMJ发表述评]:脓毒症免疫治疗与试验设计的影响已关闭评论
Editorials Immunotherapies for sepsis and the impact of study design John H Powers III, Charles Natanson BMJ 2025; 388 doi: https://doi.org/10.1136/bmj.r48 (Published 15 January 2025)Cite this as: BMJ 2025;388:r48 Enrolling the right number and type of patient is crucial Sepsis is a life threatening syndrome initiated by microorganisms.1 Severe and often lethal injuries (eg, shock, multiorgan failure, and metabolic derangements) are the manifestation o...
阅读全文
[ICU Management & Practice]: 早期活动,预防谵妄以及长期认知功能已关闭评论
Early Mobilisation, Delirium Prevention and Long-Term Cognitive Function In ICU Tue, 1 Oct 2024 ICU Management & Practice, Volume 24 - Issue 4, 2024 Early mobilisation showed promising positive effects in preventing and shortening delirium and improving long-term cognitive function. Further research is required to confirm its benefits and to identify the best protocol. Introduction In recent years, an increasing demand for critical care s...
阅读全文
[Intensive Care Med发表论文]:感染性休克患者氟氢可的松的量效关系已关闭评论
Fludrocortisone dose–response relationship in septic shock: a randomised phase II trial Walsham, J., Hammond, N., Blumenthal, A. et al. Intensive Care Med (2024). https://doi.org/10.1007/s00134-024-07616-z Abstract Background The combination of intravenous hydrocortisone and enteral fludrocortisone may reduce mortality in patients with septic shock. The optimal dose and reliability of absorption of fludrocortisone in critically ill patients are unclear. ...
阅读全文
[Clin Infect Dis发表论文]:ReSTORE研究中接受瑞扎芬净或卡泊芬净随机分组前念珠菌培养阳性患者的治疗预后已关闭评论
Treatment Outcomes Among Patients With a Positive Candida Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study  Alex Soriano,  Patrick M Honore,  Oliver A Cornely,  et al Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 672–681, https://doi.org/10.1093/cid/ciae363 Abstract Background Rezafungin, a novel, once-weekly echinocandin for the treatment o...
阅读全文
[BMJ发表论文]:胸腺肽α1治疗脓毒症的疗效与安全性已关闭评论
Research The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial Jianfeng Wu, Fei Pei, Lixin Zhou, et al BMJ 2025; 388 doi: https://doi.org/10.1136/bmj-2024-082583 (Published 15 January 2025)Cite this as: BMJ 2025;388:e082583 Abstract Objective To evaluate whether the immunomodulatory drug thymosin α1 reduces mortality in adults with sepsis. Design Multicentre, double...
阅读全文
[ICU Management & Practice]: 接受ECMO治疗的危重病患者的抗生素剂量已关闭评论
Antimicrobial Dosing in Critically Ill Patients on ECMO In ICU Mon, 14 Oct 2024 Extracorporeal membrane oxygenation (ECMO) is used to support critically ill patients, but its impact on antimicrobial pharmacokinetics (PK) and pharmacodynamics (PD) presents significant challenges. ECMO circuits can affect drug delivery, leading to the sequestration of drugs, changes in the volume of distribution (Vd), decreased clearance, and longer elimination half-life...
阅读全文
×
腾讯微博